Arey, Zomato wale Deepinder Goyal ka naya health-tech venture 'Temple' launch ho gaya hai! Pehle 100 units early access ke liye shipping start ho gayi hai. Yeh device Near-Infrared Spectroscopy (NIRS) use karta hai brain mein blood flow aur oxygenation track karne ke liye, taaki athletes aur high performers ko attention, stress, focus jaisi cheezon par insights mil sakein. Apple Watch ya Oura Ring jaise devices se alag, yeh direct temple area se data leta hai jahan signal better milta hai.
Market ki baat karein toh, global wearables market kaafi tezi se badh raha hai, 2026 tak $91 billion aur 2035 tak $181 billion tak pahunchne ka estimate hai. Temple ismein neurotech ki niche mein entry maar raha hai, jise woh 'final frontier' of health keh rahe hain. Company ne seed funding mein $54 million raise kiye hain aur valuation $190 million hai, jo Goyal ke track record ko dekh kar lagta hai.
Par yahan ek bada twist hai! User data privacy ko lekar kaafi sawaal uth rahe hain. Temple ki terms of service mein ek clause hai jo company ko user ke device se upload kiye gaye content ko use, reproduce aur distribute karne ka broad license deta hai. Yeh brain activity data ke liye ek serious concern hai, kyunki users ko dar hai ki unka sensitive personal information kahan use hoga. Halanki Temple keh raha hai ki data internal rakha jayega, par yeh broad license ek uncertainty create karta hai. Saath hi, NIRS technology consumer level par abhi bhi early stage mein hai, jise aur validation ki zaroorat hai.
Temple ko innovation aur user trust dono ko balance karna hoga. Technology ko practical, reliable aur secure banana zaroori hai. User privacy ko lekar clarity aur strong policies hi iske future ko decide karengi.
